Essex Financial Services’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$664K Sell
2,489
-248
-9% -$67.2K 0.04% 376
2025
Q4
$687K Buy
2,737
+278
+11% +$73.8K 0.04% 370
2025
Q3
$706K Buy
2,459
+87
+4% +$23.3K 0.04% 342
2025
Q2
$623K Buy
2,372
+8
+0.3% +$1.95K 0.04% 365
2025
Q1
$550K Sell
2,364
-45
-2% -$10.9K 0.04% 360
2024
Q4
$552K Sell
2,409
-105
-4% -$24.1K 0.04% 358
2024
Q3
$555K Buy
2,514
+108
+4% +$23.7K 0.04% 357
2024
Q2
$541K Sell
2,406
-22
-0.9% -$4.47K 0.04% 361
2024
Q1
$530K Sell
2,428
-251
-9% -$55.3K 0.05% 313
2023
Q4
$609K Buy
2,679
+9
+0.3% +$1.89K 0.06% 267
2023
Q3
$537K Sell
2,670
-437
-14% -$92.2K 0.06% 265
2023
Q2
$644K Buy
3,107
+58
+2% +$11.3K 0.07% 241
2023
Q1
$601K Sell
3,049
-36
-1% -$7.41K 0.06% 259
2022
Q4
$624K Buy
3,085
+60
+2% +$11.7K 0.07% 244
2022
Q3
$532K Sell
3,025
-1
-0% -$205 0.06% 242
2022
Q2
$609K Buy
3,026
+5
+0.2% +$1.07K 0.07% 247
2022
Q1
$684K Hold
3,021
0.07% 241
2021
Q4
$815K Hold
3,021
0.08% 227
2021
Q3
$730K Sell
3,021
-838
-22% -$211K 0.08% 225
2021
Q2
$845K Hold
3,859
0.12% 176
2021
Q1
$845K Buy
3,859
+317
+9% +$63.6K 0.15% 147
2020
Q4
$619K Buy
3,542
+121
+4% +$20.9K 0.12% 167
2020
Q3
$553K Sell
3,421
-19
-0.6% -$3.01K 0.14% 145
2020
Q2
$491K Buy
3,440
+19
+0.6% +$2.63K 0.15% 135
2020
Q1
$371K Sell
3,421
-4,033
-54% -$581K 0.13% 153
2019
Q4
$1.08M Buy
7,454
+467
+7% +$67.4K 0.3% 81
2019
Q3
$1.01M Buy
6,987
+115
+2% +$16.8K 0.33% 80
2019
Q2
$1.02M Sell
6,872
-735
-10% -$103K 0.3% 79
2019
Q1
$1M Sell
7,607
-186
-2% -$22.9K 0.3% 79
2018
Q4
$846K Sell
7,793
-47
-0.6% -$6.3K 0.26% 87
2018
Q3
$1.17M Sell
7,840
-29
-0.4% -$4.41K 0.26% 88
2018
Q2
$1.21M Sell
7,869
-174
-2% -$26.3K 0.29% 81
2018
Q1
$1.12M Sell
8,043
-36
-0.4% -$5.29K 0.22% 108
2017
Q4
$1.11M Sell
8,079
-93
-1% -$12.3K 0.26% 86
2017
Q3
$1.06M Sell
8,172
-204
-2% -$27.2K 0.26% 86
2017
Q2
$1.11M Hold
8,376
0.23% 107
2017
Q1
$1.03M Hold
8,376
0.24% 104
2016
Q4
$924K Hold
8,376
0.2% 115
2016
Q3
$989K Hold
8,376
0.24% 104
2016
Q2
$937K Buy
8,376
+163
+2% +$17.5K 0.23% 107
2016
Q1
$826K Hold
8,213
0.2% 113
2015
Q4
$872K Sell
8,213
-342
-4% -$35.3K 0.21% 117
2015
Q3
$797K Buy
8,555
+128
+2% +$13.2K 0.21% 115
2015
Q2
$878K Buy
8,427
+174
+2% +$18.1K 0.23% 109
2015
Q1
$894K Sell
8,253
-653
-7% -$67.2K 0.23% 112
2014
Q4
$826K Sell
8,906
-169
-2% -$14.9K 0.22% 118
2014
Q3
$793K Hold
9,075
0.24% 105
2014
Q2
$798K Hold
9,075
0.24% 105
2014
Q1
$766K Hold
9,075
0.25% 102
2013
Q4
$712K Buy
9,075
+117
+1% +$9.98K 0.24% 104
2013
Q3
$763 Buy
8,958
+233
+3% +$19.6K 0.24% 91
2013
Q2
$750K Buy
+8,725
New +$724K 0.26% 94

Other funds holding LH

Essex Financial Services's LH Position: Q1 2026 in Review

Essex Financial Services reduced its Labcorp (LH) stake by 9.1% in Q1 2026, selling an estimated $67.2K and leaving 2,489 shares worth $664K. The position accounts for 0.04% of the portfolio, ranked #376.

Essex Financial Services first reported a position in LH in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.21M in Q2 2018. 1,031 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Essex Financial Services held 2,489 shares of Labcorp worth $664K as of Q1 2026.
  • Essex Financial Services sold 248 Labcorp shares in Q1 2026, an estimated $67.2K.
  • Labcorp made up 0.04% of Essex Financial Services's portfolio in Q1 2026, its #376 holding.
  • Essex Financial Services first reported a position in Labcorp in Q2 2013 and has held it in 52 quarters since.
  • Essex Financial Services's Labcorp position peaked at $1.21M in Q2 2018.
  • 1,031 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Essex Financial Services's 13F filing for Q1 2026, filed 24 Apr 2026.